All Articles
This article offers a summary of follicular lymphoma, a type of slow-growing non-Hodgkin lymphoma, and discusses the risk factors, symptoms, and treatment options for this disease. Read More ›
When diagnosed with cancer, it is important to focus on your entire well-being in addition to treating the cancer. Part of focusing on overall health includes taking a deep look at nutrition. Here are 10 tips on how to combat malnutrition during cancer treatment. Read More ›
William and Penny Hamilton created this beautifully symbolic art piece, which celebrates their warm bond together and represents the various stages of dealing with a cancer diagnosis. Read More ›
Read Erica Stum's thoughtful exploration of faith in relation to a cancer diagnosis. Read More ›
Dr. Sekeres and Dr. Gilligan examine the hidden problem of uniformed patients, and offer tips for patients to better communicate with and understand their doctors. Read More ›
Maryann Wahmann is the 2016 Hero of Hope Patient Award winner. Over 7 years, she had 7 colonoscopies, 7 endoscopies, and several wrong diagnoses before being diagnosed with carcinoid cancer, a type of neuroendocrine tumor (NET). Read More ›
By Jeff Pascal
Saying a few good words about cancer may seem a daunting task. However, lately it has occurred to me that my journey with cancer has some bright spots. It all began on March 17, 2014. The day you learn you might have cancer is a date you never forget. Read More ›
By Greg Kelly
Retiree Greg Kelly has a passion and affinity for model building. Read More ›
In March 2017, the FDA approved Kisqali (ribociclib), in combination with an aromatase inhibitor, for the first-line treatment of postmenopausal women with HR-positive, HER2-negative advanced or metastatic breast cancer. Read More ›
In March 2017, the FDA approved Keytruda (pembrolizumab), anti-PD-1 immunotherapy, for the treatment of patients with classical Hodgkin lymphoma who are not responding to other therapy or whose disease (relapsed) returned after 3 or more therapies. Keytruda was previously approved for several cancers. Read More ›